Published in Nephrol Dial Transplant on January 01, 1988
The importance of residual renal function in chronic dialysed patients. J Med Life (2010) 0.78
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico. PLoS One (2016) 0.77
Growth of prepubertal children on dialysis. Pediatr Nephrol (2007) 0.76
β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes. BMC Nephrol (2017) 0.75
Renal dysfunction accompanying oral creatine supplements. Lancet (1998) 2.35
Survivors of acute renal failure who do not recover renal function. QJM (1996) 2.18
Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet (1998) 1.88
Biochemical monitoring of cancer. A review. Ann Clin Biochem (1976) 1.83
Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br J Cancer (1973) 1.83
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Renal proximal dysfunction in patients with rheumatic diseases. Br Med J (Clin Res Ed) (1984) 1.57
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens (2007) 1.54
Sodium dodecyl sulphate polyacrylamide gel electrophoresis patterns of proteinuria in various renal diseases of childhood. Pediatr Nephrol (1991) 1.47
Acute-on-chronic renal failure and hyponatraemia associated with severe hypothyroidism. Nephrol Dial Transplant (1993) 1.45
Individual kidney function before and after renal angioplasty. Lancet (1998) 1.44
Quantitation of the response of lymphocytes in culture to specific and non-specific stimulation. Int Arch Allergy Appl Immunol (1967) 1.44
[Degradation of thymidine by transformed lymphocytes]. Rev Fr Etud Clin Biol (1965) 1.43
Icodextrin allergy in a peritoneal dialysis patient. Nephrol Dial Transplant (1998) 1.43
Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer (1969) 1.41
Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder. Cancer (1971) 1.41
Acute interstitial nephritis due to over-the-counter ibuprofen in a renal transplant recipient. Nephrol Dial Transplant (1998) 1.40
Tackling antibiotic resistance. Br J Gen Pract (1999) 1.39
Unusual bacterial infections of the urinary tract in diabetic patients--rare but frequently lethal. Nephrol Dial Transplant (2001) 1.38
Rhabdomyolysis and a "greenhouse effect". Lancet (1990) 1.38
Congestive heart failure--can the nephrologist help? J R Coll Physicians Lond (2000) 1.38
Immunologically stimulated human peripheral blood lymphocytes in vitro. I. Morphological changes. Int Arch Allergy Appl Immunol (1966) 1.37
C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol (1984) 1.34
Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant (2000) 1.32
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer (1980) 1.31
Cancer of the urinary tract. Adv Cancer Res (1970) 1.28
Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet (1983) 1.27
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer (1985) 1.25
Cell proliferation in Burkitt tumours. Eur J Cancer (1966) 1.25
Teicoplanin-resistant coagulase-negative staphylococcus. Lancet (1986) 1.25
Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol (1983) 1.25
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Cause of death in acute renal failure. Nephrol Dial Transplant (1992) 1.23
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
Cell death in normal and malignant tissues. Adv Cancer Res (1975) 1.22
Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol (1984) 1.22
Isolated sarcoid granulomatous interstitial nephritis: review of five cases at one center. Clin Nephrol (2001) 1.21
Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg (1984) 1.20
Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant (2001) 1.19
The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer (1988) 1.18
Tubular dysfunction and microalbuminuria in insulin dependent diabetes. Arch Dis Child (1988) 1.16
Results of the MRC myelomatosis trials for patients entered since 1980. Hematol Oncol (1988) 1.15
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer (1993) 1.15
Influenza vaccine-induced rhabdomyolysis leading to acute renal transplant dysfunction. Nephrol Dial Transplant (2005) 1.15
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer (1985) 1.15
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
CEA and tumor markers. Semin Oncol (1976) 1.13
Acute phase reactant proteins in cancer. Adv Cancer Res (1979) 1.12
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol (1989) 1.10
Acute renal failure--a dangerous condition. JAMA (1996) 1.09
Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int (1997) 1.09
Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron (1997) 1.08
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring. Br J Cancer (1980) 1.08
Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial. J Clin Pathol (1984) 1.07
Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease. Nephrol Dial Transplant (1994) 1.05
Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J (2006) 1.04
Proliferative activity of leukaemic cells at various stages of acute leukaemia of childhood. Br J Haematol (1968) 1.04
The biology of cell death in tumours. Cell Tissue Kinet (1973) 1.03
Severe acute renal failure in adults: place of care, incidence and outcomes. QJM (2005) 1.02
The thoracic duct lymph in Hodgkin's disease. II. Quantitative analysis of the cellular composition of the lymph. Int J Cancer (1971) 1.02
Lymphocyte infiltration in bladder carcinoma. Rev Eur Etud Clin Biol (1970) 1.01
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom. Anaesthesia (2003) 0.99
Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant (1995) 0.99
Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer (1972) 0.99
Serum beta 2-microglobulin and human immunodeficiency virus infection. AIDS (1987) 0.99
MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney Int (2006) 0.99
Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet (1980) 0.98
DNA synthesis and DNA content of leucocytes in acute leukaemia. Nature (1967) 0.97
Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97
Blood muramidase activity in colorectal cancer. Br Med J (1974) 0.97
A case of eosinophilic peritonitis treated with oral corticosteroids. Perit Dial Int (2000) 0.96
Disorganization of mouse bladder epithelium induced by 2-acetylaminofluorene and 4-ethylsulfonylnaphthalene-1-sulfonamide. J Natl Cancer Inst (1971) 0.96
Metabolic alkalosis induced by 'Panadol Soluble'. Lancet (1985) 0.96
The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail (1995) 0.95
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer (1994) 0.95
Complement activation and C1q binding activity in haemodialysis. Proc Eur Dial Transplant Assoc (1981) 0.95
DNA metabolism of the immunoglobulin-containing cells in the lymph nodes of rats. J Reticuloendothel Soc (1965) 0.95
Long-term prognostic value of serum beta 2 microglobulin in myelomatosis. Br J Haematol (1990) 0.95
'Surgical' peritonitis in the CAPD patient. Ann R Coll Surg Engl (1998) 0.95
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Ann Rheum Dis (2004) 0.94
Eosinophilic colitis due to rifampicin. Lancet (1994) 0.94
Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol (1980) 0.94
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1). Diabet Med (2011) 0.94
Beta-blocker withdrawal syndrome. Lancet (1979) 0.94
Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer. Br J Cancer (1974) 0.94
Acute phase reactant proteins in prostatic cancer. Br J Urol (1977) 0.93
Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant (1999) 0.93
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. Cancer (1978) 0.93
The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer (1975) 0.93
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer (1983) 0.92
The evolution of tumour cell populations in human bladder cancer. Br J Urol (1969) 0.92
Plasma protein profiles and prognosis in gastric cancer. Br J Cancer (1982) 0.92
Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practice. Eur J Cancer (1978) 0.91
Accumulation of calcium in the intramitochondrial dense bodies in mice. Exp Cell Res (1972) 0.91
Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM (1998) 0.91